Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.

Sondak VK, Liu PY, Tuthill RJ, Kempf RA, Unger JM, Sosman JA, Thompson JA, Weiss GR, Redman BG, Jakowatz JG, Noyes RD, Flaherty LE
J Clin Oncol. 2002 20 (8): 2058-66

PMID: 11956266 · DOI:10.1200/JCO.2002.08.071

MeSH Terms (13)

Adjuvants, Immunologic Adult Aged Aged, 80 and over Cancer Vaccines Disease-Free Survival Female Follow-Up Studies Humans Male Melanoma Middle Aged Proportional Hazards Models

Connections (1)

This publication is referenced by other Labnodes entities: